MMO HEALTH STAFFING

Connecting Healthcare Facilities with Exceptional Healthcare Professionals for Continuity of Care & Operational Efficiency while managing work force challenges.

[emmex102WWM @emmex10]

Governance begins with clarity: Who decides? Who follows through? Who needs to know? Make responsibility visible.
https://t.co/p5TaiWkvgT

[MMO HEALTH STAFFING @mmonursing]

Check out our latest blog on our website: How Process Optimization Can Solve Your Healthcare Staffing Shortages. Explore smarter staffing strategies for stronger care. https://t.co/vs1SkwWbIN #MMOHealthStaffing #HealthcareStaffing

[emmex102WWM @emmex10]

Credentials matter. But competence also includes experience, judgment, communication, accountability and character. Due diligence isn't distrust. It is understanding what stands behind the trust you're being asked to give.

[emmex102WWM @emmex10]

Having health information isn't the same as an information system. Where is it? Who can access it? Who keeps it current? Who must know when it changes? Useful information must be available when responsibility requires it

[emmex102WWM @emmex10]

A decision is incomplete until someone owns the follow-through.

Who schedules it?
Who communicates it?
Who confirms it happened?

A decision without a named owner can become a recurring crisis.

[emmex102WWM @emmex10]

Before adding another health service, ask what problem it is solving.
More providers, caregivers and appointments can mean more support: but also more complexity.
More care is not automatically more coordinated care.

[MMO HEALTH STAFFING @mmonursing]

Montefiore 12 utilization review nurse roles eliminated as AI takes over workflows.
Read our latest blog post full analysis.

https://t.co/nMVeXUM6et

#AI #Nursing

[emmex102WWM @emmex10]

Action is not always the first responsible step.

Sometimes the first step is seeing what remains unclear: authority, responsibility, information, risk, and backup.

Assessment creates direction before urgency creates confusion.

[MMO HEALTH STAFFING @mmonursing]

Happy 250th, America. From 1776 healers to 2026, excellence endures.

Read on our blog page:
https://t.co/UNlNync3Ob

#America250 #HealthcareLegacy #MMOHealthStaffing

[MMO HEALTH STAFFING @mmonursing]

Ambulatory care is the future. 2026 data shows staffing shifting to outpatient clinics. MMO Health Staffing provides specialized local talent pools to support your facility’s growth and efficiency.

https://t.co/1J4ALIdRzO
1-646-212-4490
#HealthcareStaffing

[MMO HEALTH STAFFING @mmonursing]

The 2026 Reset: Reactive staffing is unsustainable. Replacing one nurse costs $60k. Avoid the overtime trap with capacity-based planning. Lean on our 100+ years of clinical expertise to stabilize.

https://t.co/yGDEaBgMZW

#HealthcareStaffing #Nursing #Care

[MMO HEALTH STAFFING @mmonursing]

This Memorial Day, we honor the brave veterans who served our nation and now serve our communities in healthcare. Your transition from the front lines to patient care reflects a life dedicated to others.

1-646-212-4490
https://t.co/QdBAq60iuo

#MemorialDay

[Dr. Pat Soon-Shiong @DrPatrick]

Cancer is a shape shifting disease. We have figured a way to outsmart it through the power of IL-15 and natural killer cells. By 2026 we will grow trillions of natural killer cells from healthy donors and generate the 'world bank of natural killer cells' which can be administered to any patient without donor matching. That is how natural killer cells work.

@SpecialReport @BretBaier

[MMO HEALTH STAFFING @mmonursing]

Interesting Video Shared by @DrPatrick Doing great research on cancer immunotherapy treatment

https://t.co/v0SeU2WCj8

[ImmunityBio, Inc. @ImmunityBio]

ImmunityBio Founder, Executive Chairman, and Global Chief Scientific and Medical Officer Dr. Patrick Soon-Shiong recently joined the @OncBrothers podcast to explore the science and patient impact behind what it takes to be a true game-changer in oncology. This wasn’t just a discussion about a drug, but a conversation about rebuilding the immune system and rethinking what the future of cancer care must look like.

Listen in and hear how ImmunityBio is pushing immunotherapy forward, starting with the immune system itself: https://t.co/XnYYuha6ac

[Dr. Pat Soon-Shiong @DrPatrick]

I have received so many enquiries as to how did the Saudi FDA work with us to grant approval of Anktiva for lung cancer and bladder cancer. We submitted over 1.6 million pages of data ! The SFDA thoroughly reviewed these and on the basis of the clinical results made the decision to provide accelerated approval for Anktiva in lung cancer  ..the FIRST IN THE WORLD!!

Explaining how the SFDA went about their review and their approval is best described in their own words below: 

“ Positive Results Demonstrated in Clinical Studies
The approval of Anktiva is based on a comprehensive evaluation of all available evidence—including efficacy, safety, and quality—in accordance with regulatory requirements. For NSCLC, results from a single-arm clinical trial in patients who had previously not responded to one or more therapies, including immune checkpoint inhibitors, demonstrated a potential improvement in survival. Based on these findings, the SFDA granted conditional approval for this indication. A confirmatory trial to demonstrate long-term clinical benefit is required to maintain this approval status.
For NMIBC, clinical trial results sowed a complete response rate of 62%. The approval for this indication was based on the complete response rate as the primary endpoint. Collectively, these results led the SFDA to consider Anktiva as a new treatment option for patients with limited therapeutic alternatives, contributing to improved disease and survival outcomes.

Sustained Efforts to Achieve National Objectives
This approval reflects the SFDA’s continued commitment to innovation and expanding access to advanced treatment options, thereby enhancing the quality of healthcare in alignment with the goals of the Health Sector Transformation Program, one of the key initiatives of Saudi Vision 2030.”

[MMO HEALTH STAFFING @mmonursing]

https://t.co/NKDjP4Vumd

[Dr. Pat Soon-Shiong @DrPatrick]

Seeing is believing. The patient with multiple bone tumors after failing standard of care and complete response after just 4 doses of our targeted NK cells. And now in ongoing remission 7 months with no further treatment. The power of NK cells is self evident.

Outpatient treatment without lymphodepletion and toxic chemo. A paradigm change

https://t.co/pBuLJz3Mer

[Dr. Pat Soon-Shiong @DrPatrick]

Revealed at our summit: building and teaching with machine vision and AI, the world’s first robot to manufacture NK cells at scale! Will be installed in next 3 months and then we change the cost of cell therapy forever to make it available to so many who need immune restoration

[MMO HEALTH STAFFING @mmonursing]

Clip of Nephrologist Dr. Shari Lewis-Foster Finding Inspiration from a d... https://t.co/T5cCscJ9WF via @YouTube